» Articles » PMID: 26249265

Cortical Thinness and Volume Differences Associated with Marijuana Abuse in Emerging Adults

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2015 Aug 8
PMID 26249265
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of marijuana (MJ) use among youth and its legalization for medical or recreational use has intensified public health endeavors of understanding MJ effects on brain structure and function. Studies indicate that MJ use is related to impaired cognitive performance, and altered functional brain activation and chemistry in adolescents and adults, but MJ effects on brain morphology in emerging adults are less understood.

Methods: Fifteen MJ users (age 21.8±3.6, 2 females) and 15 non-user (NU) participants (age 22.3±3.5, 2 females) were included, demographically matched on age, education and alcohol use. High-resolution structural MR images were acquired at 3Tesla. Cortical thickness (CT) and volumetric analyses were performed using Freesurfer. A priori regions of interest (ROI) included orbitofrontal and cingulate cortices, amygdala, hippocampus and thalamus.

Results: Whole brain CT analysis did not result in significant group differences in a priori ROIs but revealed MJ users had significantly less CT (i.e., thinness) in right fusiform gyrus (rFG) compared to NU (p<0.05). Thalamic volume was significantly smaller in MJ users compared to NU (right, p=0.05; left, p=0.01) and associated with greater non-planning (p<0.01) and overall impulsivity (p=0.04). There were no other group differences.

Conclusions: RFG cortical thinness and smaller thalamic volume in emerging adults is associated with MJ abuse. Furthermore, smaller thalamic volume associated with greater impulsivity contributes to growing evidence that the thalamus is neurobiologically perturbed by MJ use. Collectively, altered thalamic and rFG structural integrity may interfere with their known roles in regulating visuoperceptual and object information processing.

Citing Articles

Association Between Cannabis Use and Brain Structures: A Mendelian Randomization Study.

Li J, Yin Z, Yu Z, Li J, Yang L Cureus. 2024; 16(8):e65922.

PMID: 39221390 PMC: 11365007. DOI: 10.7759/cureus.65922.


Cortical Morphology in Cannabis Use Disorder: Implications for Transcranial Direct Current Stimulation Treatment.

Soleimani G, Towhidkhah F, Saviz M, Ekhtiari H Basic Clin Neurosci. 2024; 14(5):647-662.

PMID: 38628838 PMC: 11016884. DOI: 10.32598/bcn.2021.3400.1.


Adolescent substance use initiation and long-term neurobiological outcomes: insights, challenges and opportunities.

Boer O, El Marroun H, Muetzel R Mol Psychiatry. 2024; 29(7):2211-2222.

PMID: 38409597 DOI: 10.1038/s41380-024-02471-2.


Testing the consequences of alcohol, cannabis, and nicotine use on hippocampal volume: a quasi-experimental cotwin control analysis of young adult twins.

Harper J, Wilson S, Bair J, Hunt R, Thomas K, Malone S Psychol Med. 2023; 53(6):2671-2681.

PMID: 37310301 PMC: 10123841. DOI: 10.1017/S0033291721004682.


Thalamocortical Development: A Neurodevelopmental Framework for Schizophrenia.

Benoit L, Canetta S, Kellendonk C Biol Psychiatry. 2022; 92(6):491-500.

PMID: 35550792 PMC: 9999366. DOI: 10.1016/j.biopsych.2022.03.004.


References
1.
Hester R, Nestor L, Garavan H . Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology. 2009; 34(11):2450-8. PMC: 2743772. DOI: 10.1038/npp.2009.67. View

2.
Wang X, Dow-Edwards D, Keller E, Hurd Y . Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience. 2003; 118(3):681-94. DOI: 10.1016/s0306-4522(03)00020-4. View

3.
Silveri M, Jensen J, Rosso I, Sneider J, Yurgelun-Todd D . Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res. 2011; 191(3):201-11. PMC: 3065822. DOI: 10.1016/j.pscychresns.2010.10.005. View

4.
Weinstein A, Miller H, Bluvstein I, Rapoport E, Schreiber S, Bar-Hamburger R . Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study. Am J Drug Alcohol Abuse. 2013; 40(1):16-22. DOI: 10.3109/00952990.2013.819362. View

5.
Tzilos G, Cintron C, Wood J, Simpson N, Young A, Pope Jr H . Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict. 2005; 14(1):64-72. DOI: 10.1080/10550490590899862. View